DDA has given Emergency use Authorization of Vero Cell vaccine in Nepal
EUA of covid 19 vaccine (Vero cell), inactivated manufactured by BIBP(under sinopharm)
Department of Drug Administation – DDA notify that the conditional permission has been granted for emergency use of authorization of covid-19 vaccine (Vero Cell), Inactivated vaccine manufactured by Beijing Institute of Biological Products Co. Ltd. (BIBP), China under Sinopharm against COVID-19 in Nepal as per the departmental decision dated 16th feb 2021.
Name of Product: SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Name of Manufacturer: Beijing Institute of Biological Product Co. Ltd. (BIBP), China under Sinopharm
Dosage form: Solution for injection. Each 0.5 ml vaccine contains 6.5 U of inactivated SARS-CoV-2 antigen
Route of Administration: Intramuscular
Composition: Each dose of 0.5 ml of vaccine contains
Disodium hydrogen phosphate, sodium chloride, sodium dihydrogen phosphate, Aluminum hydroxide.